Market Size of China Self-Monitoring Blood Glucose Devices Industry
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 1.30 Billion |
| Market Size (2029) | USD 1.60 Billion |
| CAGR (2024 - 2029) | 6.20 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
China Self-Monitoring Blood Glucose Devices Market Analysis
The China Self-Monitoring Blood Glucose Devices Market size is estimated at USD 1.30 billion in 2024, and is expected to reach USD 1.60 billion by 2029, growing at a CAGR of 6.20% during the forecast period (2024-2029).
Blood Glucose Monitoring increases patients' awareness of glucose values, which supports healthy lifestyle choices. Blood Glucose Monitoring values help in providing feedback and guidance on how to make health behavior changes when needed. Continued elevation in blood glucose levels in diabetes patients can contribute to progressive complications such as renal, nerve, and ocular damage. Appropriate and timely monitoring of blood glucose allows the successful management of out-of-range blood glucose levels, minimizing diabetic-related health complications.
As a long-term strategy, China is extending efforts at health promotion, detection, and control of diabetes with academic medical centers (AMCs) and hospitals with effective primary care. AMCs are usually overcrowded with patients with simple conditions, while the primary care system is under-equipped with basic medical infrastructure and an under-qualified workforce. The State Council has encouraged health system integration by promoting a hierarchical medical system, a policy that attempts to attract more patients to primary health centers before going to AMCs.
Innovative technologies such as digital health apps that display and summarize individual blood glucose measurements and incorporate additional relevant data such as insulin doses, meals/snacks, and physical activity, can further support self-management while decreasing disease burden and benefitting overall diabetes care. Integration of Blood Glucose Monitoring with insulin calculators, automated insulin titration software, and remote coaching are further developments that provide patients with poorly controlled diabetes additional support needed to improve critical outcomes, thereby enhancing the market prospects in the years to come.
China Self-Monitoring Blood Glucose Devices Industry Segmentation
Self-monitoring of blood glucose is an approach used by diabetic patients to measure their blood sugar level themselves, using a glucometer, test strips, and lancets. Based on the readings, patients can adjust or check the effect of their treatment. The China Self-Monitoring Blood Glucose Devices Market is segmented into Components. The report offers the value (in USD) and volume (in Units) for the above segments.
| Component | |
| Glucometer Devices | |
| Test Strips | |
| Lancets |
China Self-Monitoring Blood Glucose Devices Market Size Summary
The China Self-Monitoring Blood Glucose Devices Market is poised for significant growth, driven by the increasing prevalence of diabetes and the country's strategic health initiatives. As the largest population of diabetics globally, China faces a pressing need for effective diabetes management solutions. The market is characterized by a fragmented landscape with key players like Abbott, LifeScan, Roche, and Ascensia leading the charge. The government's Healthy China 2030 Plan aims to control diabetes prevalence and enhance self-management rates, further propelling market expansion. Innovative technologies, including digital health apps and integrated monitoring systems, are enhancing patient self-management capabilities, thereby reducing the disease burden and improving overall diabetes care.
The market's growth trajectory is supported by the rising demand for blood glucose test strips, which hold a substantial market share due to their recurring use and essential role in daily diabetes management. Unlike glucometers, which are one-time purchases, test strips require continuous investment, reflecting their critical importance in the monitoring process. The ongoing urbanization and lifestyle changes in China contribute to the increasing diabetes population, necessitating robust monitoring solutions. As the healthcare system evolves with a focus on primary care and health promotion, the self-monitoring blood glucose devices market is expected to witness sustained growth, driven by both technological advancements and supportive government policies.
China Self-Monitoring Blood Glucose Devices Market Size - Table of Contents
-
1. MARKET DYNAMICS
-
1.1 Market Overview
-
1.2 Market Drivers
-
1.3 Market Restraints
-
1.4 Porter's Five Forces Analysis
-
1.4.1 Bargaining Power of Suppliers
-
1.4.2 Bargaining Power of Consumers
-
1.4.3 Threat of New Entrants
-
1.4.4 Threat of Substitute Products and Services
-
1.4.5 Intensity of Competitive Rivalry
-
-
-
2. MARKET SEGMENTATION
-
2.1 Component
-
2.1.1 Glucometer Devices
-
2.1.2 Test Strips
-
2.1.3 Lancets
-
-
China Self-Monitoring Blood Glucose Devices Market Size FAQs
How big is the China Self-Monitoring Blood Glucose Devices Market?
The China Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 1.30 billion in 2024 and grow at a CAGR of 6.20% to reach USD 1.60 billion by 2029.
What is the current China Self-Monitoring Blood Glucose Devices Market size?
In 2024, the China Self-Monitoring Blood Glucose Devices Market size is expected to reach USD 1.30 billion.
